Results 81 to 90 of about 395,238 (233)

Response to third rubella vaccine dose

, 2018
Limited data exist on the immunogenicity of a third dose of the measles, mumps, and rubella vaccine (MMR). In this study, our aim was to evaluate the long-term rubella immunogenicity afforded by two childhood MMR doses of the Norwegian vaccination ...
Lotta Siira, Susanne G. Dudman, Hanne Nøkleby, Regine Barlinn, Øystein R. Riise, Ingeborg S. Aaberge   +5 more
core   +1 more source

The National Health and Medical Research Council Research Impact Indicators: Unveiling Omissions and Blind Spots, and Positioning for Change

Health Promotion Journal of Australia, Volume 37, Issue 4, October 2026.
ABSTRACT Issue Addressed This study assesses how the concept of (health) research impact has been operationalised in National Health and Medical Research Council (NHMRC) Impact Case Studies, and if and how lived experience research priorities have been considered, to ascertain implications for Australian health and medical research.
Nizam Abdu, Maria Unwin, Caroline Robertson, Oliver Black (Anaiwan), Victoria J. Palmer, Amanda J. Wheeler, Amanda L. Neil   +6 more
wiley   +1 more source

Vaccination coverage for measles- and rubella-containing vaccine first dose by Region, Italy, 2013–2018.

, 2019
MCV1, measles-containing vaccine first dose; RCV1, rubella-containing vaccine first dose.
Carolina Di Paolo (8129739), Azzurra Massimi (3830245), Carla Salerno (8129754), Paolo Villari (206731), Loredana Nicoletti (8129766), Claudia Isonne (8129757), Fabio Magurano (5892404), Valentina Baccolini (5892395), Antonino Bella (53719), Carolina Marzuillo (752877), Giovanna Adamo (5892389), Annamaria Mele (8129742), Rosario Cocchiara (8129736), Sara Cianfanelli (8129745), Martina del Manso (8129760), Domenico Barbato (8129733), Melissa Baggieri (8129763), Stefania Iannazzo (4858561), Aurora Angelozzi (8129748), Fulvio Castellani (8129751), Antonietta Filia (79081)   +20 more
core   +1 more source

Vaccination in pediatric transplantation—General recommendations. A position paper by the European Reference Network TransplantChild

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 4, Page 624-636, October 2026.
Abstract Infectious diseases remain a leading cause of morbidity and mortality among pediatric transplant recipients, despite significant advances in transplantation management. Vaccination is the most effective strategy to prevent infections; however, its efficacy is hindered in solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT)
Valeria Casotti, Francesco Saglio, Adriana Balduzzi, Peter Barany, Vibeke Brix Christensen, Simona Buelli, Daniele Donà, Maja Klaudel‐Dreszler, Sara Mosca, Andrea Pietrobattista, Michele Pinon, Giusy Ranucci, Lars Wennberg, Lorenzo D'Antiga, ERN TransplantChild Working Group, Claudia Vittori, Manuela Tumino, B. Ruben Brandsema, Lisa Swartling, Silvia Garazzino, Carlo Pace Napoleone, Kai Lehmberg, Isabella Guzzo, Charlotte Roy, Nicola Pradegan, Silvia Simo Nebot, Maria Herthelius, Angelo Mazza, Enrico Aidala, Oleg Godik, Victoria Bordon Cueto De Braem, Marco Busutti, Emily Claire Argento, Marc Garcia Lorenzo, Timo Jahnukainen, Zoryana Ivanyuk   +35 more
wiley   +1 more source

Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls

Indian Journal of Community Medicine, 2010
Background: Rubella vaccination is not yet included in National Immunization Schedule in India. Serosurvey is frequently used to assess epidemiologic pattern of Rubella in a community.
Sharma Hitt, Chowdhari Sunil, Raina Tilak, Bhardwaj Subodh, Namjoshi Gajanan, Parekh Sameer   +5 more
doaj  

Deficits in Long-Term Vaccine Immunity Among Childhood Cancer Survivors Despite Revaccination Programs

Vaccines
Background: Childhood cancer survivors (CCSs) often experience impaired humoral immunity because of cancer treatments that increase their susceptibility to vaccine-preventable diseases. This study aimed to assess the seroprevalence of tetanus and rubella
Alexander Zadruzny, Eva Tiselius, Tiia Lepp, Teodora Aktas, Teghesti Tecleab, Samuel Hellman, Maja Jahnmatz, Anna Nilsson   +7 more
doaj   +1 more source

Newer vaccines (measles-rubella, human papillomavirus, rotavirus, and pneumococcal conjugate vaccine) introduction: Experience from Northern India

International Journal of Noncommunicable Diseases, 2018
Vaccines are essential to ensure that the population is immune to certain diseases, and immunization is one of the most cost-effective interventions to prevent the occurrence of the diseases.
Madhu Gupta, Kanica Kaushal, Nikita Sharma, Atul Gupta, Abu Mohammad Bashar, Suresh Dalpath, Shivani Gupta, G B Singh   +7 more
doaj   +1 more source

Diagnosis and Management of Infectious Encephalitis in Adults: Guidelines From the European Academy of Neurology and European Society of Clinical Microbiology and Infectious Diseases

European Journal of Neurology, Volume 33, Issue 10, October 2026.
ABSTRACT Background Encephalitis is difficult to diagnose and manage, posing a challenge to clinicians. Since the last European guidelines were published in 2010, novel causes have emerged, diagnostic processes have evolved and treatments assessed which need to be reflected in updated guidelines.
Julia Granerod, Johann Sellner, Jean‐Paul Stahl, Sylviane Defres, Alexandra Mailles, Erich Schmutzhard, Elisabeth Aurelius, Thomas Whitfield, Luca Massacesi, Maarten J. Titulaer, Pille Taba, Benedict D. Michael, Tehmina Bharucha, Lance Turtle, Brendan Sargent, Arina Tamborska, Jonathan Cattrall, Yun Huang, Eva Maria Hodel, Suzannah Lant, Glynn Webb, Rajish S. K. Shil, Shalley Dhar, Diederik van de Beek, Marie Studahl, Matthijs C. Brouwer, Uta Meyding‐Lamade, Ava Easton, Bhagteshwar Singh, Tom Solomon   +29 more
wiley   +1 more source

'MMR talk' and vaccination choices: an ethnographic study in Brighton [PDF]

, 2005
In the context of the high-profile controversy that has unfolded in the UK around the measles, mumps and rubella (MMR) vaccine and its possible adverse effects, this paper explores how parents in Brighton, southern England, are thinking about MMR for ...
Poltorak, Mike, Fairhead, James, Cassell, Jackie, Leach, Melissa   +3 more
core  

Immunogenicity of the rubella/gag vaccine insert.

, 2020
(A) ELISA measurements of Gag antibody titers upon vaccination of macaques with gag DNA prime and Rubella/gag boost. (B) Antibodies to SIV Gag were detected by Western blot on Zeptometrix antigen strips one week after stopping ART. At this time (week 28),
Jeffrey D. Lifson (7444760), Ira Berkower (8532288), Yvonne Bryson (8532282), Kate E. Broderick (8489103), Ruth M. Ruprecht (8072033), Alexei Medvedev (8532270), Margherita Rosati (396218), Konstantin Virnik (3524306), Gabrielle Walsh (8532276), Mark Lewis (393467), Barbara K. Felber (8532285), Aaron Scanlan (8532273), Frances Dayton (8532279)   +12 more
core   +1 more source